SEC Form 4 · accession 0001100682-26-000134
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nancy C Andrews
Director
Period of report
Aug 18, 2026
Accepted (ET)
Aug 20, 2026 · 4:31 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 18, 2026 | M | 573 | $164.30 | A | 2,011 | D | |
| Common Stock | Aug 18, 2026 | S | 573 | $285.24 | D | 1,438 | D | |
| Common Stock | holding | — | — | — | 3,964 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $164.30 | Aug 18, 2026 | M | 573 | D | Mar 2, 2021 | Mar 2, 2027 | Common Stock | 573 | 0 | D |